Truist sees ‘very little substance to alleged claims’ in Primerica short report

Truist notes that a short seller has published a note on Primerica and based on the analyst’s review of the public-facing information its reading is that there is “very little substance to the alleged claims and the implication of wrong-doing.” The firm, which notes that it has not seen the detail behind the paywall and that the company has not yet published a response to this report, maintains a Buy rating and $275 price target on Primerica shares.